ArticleThe Journal of clinical endocrinology and metabolism2009
The approach to the patient with paraganglioma.
Article in The Journal of clinical endocrinology and metabolism, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 77 citations in OpenAlex.
- Genetic Variants in Patients with Multiple Head and Neck Paragangliomas: Dilemma in Management.Biomedicines · 2021Article
- De novo SDHB gene mutation in a family with extra-adrenal paraganglioma.Familial cancer · 2020Article
- A systematic review on the genetic analysis of paragangliomas: primarily focused on head and neck paragangliomas.Neoplasma · 2019Review
- SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations.Journal of cancer research and clinical oncology · 2017Article
- Radiological Surveillance Screening in Asymptomatic Succinate Dehydrogenase Mutation Carriers.Journal of the Endocrine Society · 2017Review
- Calculating the optimal surveillance for head and neck paraganglioma in SDHB-mutation carriers.Familial cancer · 2017Article
- Review of Pediatric Pheochromocytoma and Paraganglioma.Frontiers in pediatrics · 2017Review
- Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome.Endocrine-related cancer · 2016Article
- HIF2A gain-of-function mutations detected in duodenal gangliocytic paraganglioma.Endocrine-related cancer · 2016Article
- Resection of a large carotid paraganglioma in Carney-Stratakis syndrome: a multidisciplinary feat.BMJ case reports · 2015Article
- Functional cardiac paraganglioma associated with a rare SDHC mutation.Endocrine pathology · 2014Article
- Diagnosis of extra-adrenal phaeochromocytoma after nephrectomy.Central European journal of urology · 2014Article
- Management and follow up of extra-adrenal phaeochromocytoma.Central European journal of urology · 2014Review
- Ectopic acromegaly due to growth hormone releasing hormone.Endocrine · 2013Review
- 10 rare tumors that warrant a genetics referral.Familial cancer · 2013Review
- [A 47-year-old patient with paroxysmal arterial hypertension and gastric tumors].Der Internist · 2012Article
- Somatic mutation analysis of the SDHB, SDHC, SDHD, and RET genes in the clinical assessment of sporadic and hereditary pheochromocytoma.Hormones & cancer · 2012Article
- Head and neck paragangliomas: clinical and molecular genetic classification.Clinics (Sao Paulo, Brazil) · 2012Review
- Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma.Clinical chemistry · 2011Article
- Laparoscopic organ-sparing resection of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.World journal of surgery · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The multidisciplinary management of patients with paragangliomas and pheochromocytomas remains challenging. The cornerstone of excellent multidisciplinary management of such patients is genetic classification and management in a tertiary care referral center. Up to one third of all symptomatic presentations of pheochromocytoma or paraganglioma are due to germline mutations in one of six genes defining multiple endocrine neoplasia type 2, von Hippel-Lindau disease, neurofibromatosis type 1, and the paraganglioma syndromes types 1, 3, and 4. This genetic classification forms the basis early diagnosis and follow-up including management of relatives. Easily available clinical information such as tumor location and number, age, gender, and family history must be used to prioritize which gene should be tested. Mutation carriers should undergo regular check-up to detect and treat metachronous paraganglial and extraparaganglial tumors, and depending on syndrome, other extraparaganglial neoplasias such as medullary thyroid cancer and renal clear cell carcinomas in time. Adrenal and extraadrenal retroperitoneal tumors should be operated by surgeons highly experienced in minimal invasive, endoscopic techniques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.